8Z74 image
Deposition Date 2024-04-19
Release Date 2025-01-22
Last Version Date 2025-07-02
Entry Detail
PDB ID:
8Z74
Title:
Cryo-EM structure of APJR complex with agonistic antibody
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.01 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:agonistic antibody
Chain IDs:A, B
Chain Length:130
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Soluble cytochrome b562,Apelin receptor
Gene (Uniprot):APLNR
Chain IDs:C, D
Chain Length:477
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural insights into the regulation of monomeric and dimeric apelin receptor.
Nat Commun 16 310 310 (2025)
PMID: 39747115 DOI: 10.1038/s41467-024-55555-6

Abstact

The apelin receptor (APJR) emerges as a promising drug target for cardiovascular health and muscle regeneration. While prior research unveiled the structural versatility of APJR in coupling to Gi proteins as a monomer or dimer, the dynamic regulation within the APJR dimer during activation remains poorly understood. In this study, we present the structures of the APJR dimer and monomer complexed with its endogenous ligand apelin-13. In the dimeric structure, apelin-13 binds exclusively to one protomer that is coupled with Gi proteins, revealing a distinct ligand-binding behavior within APJR homodimers. Furthermore, binding of an antagonistic antibody induces a more compact dimerization by engaging both protomers. Notably, structural analyses of the APJR dimer complexed with an agonistic antibody, with or without Gi proteins, suggest that G protein coupling may promote the dissociation of the APJR dimer during activation. These findings underscore the intricate interplay between ligands, dimerization, and G protein coupling in regulating APJR signaling pathways.

Legend

Protein

Chemical

Disease

Primary Citation of related structures